ClinicalTrials.gov record
Completed Phase 2 Interventional

UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

ClinicalTrials.gov ID: NCT00064272

Public ClinicalTrials.gov record NCT00064272. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 5:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Trial Of Encapsulized Ginger As A Treatment For Chemotherapy-Induced Nausea and Vomiting AKA IRB 2003-213

Study identification

NCT ID
NCT00064272
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
University of Michigan Rogel Cancer Center
Other
Enrollment
180 participants

Conditions and interventions

Interventions

  • ginger extract Drug
  • placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2003
Primary completion
Apr 30, 2007
Completion
Not listed
Last update posted
Oct 20, 2016

Started 2003

United States locations

U.S. sites
5
U.S. states
3
U.S. cities
4
Facility City State ZIP Site status
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601
University of Michigan Cancer Center CCOP Research Base Ann Arbor Michigan 48109-0725
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-0942
CCOP - Grand Rapids Grand Rapids Michigan 49503
MBCCOP - Our Lady of Mercy Cancer Center The Bronx New York 10466

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00064272, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 20, 2016 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00064272 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →